Skip to main content
logo
Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
At close: Jul 6, 2026

Genix Pharmaceuticals Financials Overview

Millions CAD. Fiscal year is Nov - Oct.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Revenue
--00.01--
Revenue Growth
---67.19%---
Gross Profit
--00--
Operating Income
-0.13-0.16-0.25-0.88-1.03-1.66
Net Income
-0.13-0.16-0.25-0.88-1.03-1.66
Earnings Per Share
-0.01-0.01--0.07-0.02-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash & Investments
0.010.040.010.010.010.14
Total Debt
1.151.040.820.510.180.05
Net Cash (Debt)
-1.14-1-0.8-0.5-0.170.09
Net Cash Growth
------86.81%
Net Cash Per Share
-0.02-0.02-0.01-0.01-0.000.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Operating Cash Flow
-0.1-0.12-0.19-0.22-0.22-0.43
Free Cash Flow
-0.1-0.12-0.19-0.22-0.22-0.43
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Gross Margin
--32.02%26.43%--
Operating Margin
---6061.66%-7158.82%--
Pretax Margin
---6061.66%-7158.82%--
Profit Margin
---6061.66%-7158.82%--
FCF Margin
---4624.54%-1787.27%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
PS Ratio
--730.98191.87--